| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2a
| Abdo H, Calvo Enrique L, Lopez J, Song J, Zhang M, Usoskin D, et al. Specialized cutaneous Schwann cells initiate pain sensation. Science. 2019;365:695-699 pubmed publisher |
- immunocytochemistry; mouse; 1:250; loading ...; fig 2c
| Quintes S, Brinkmann B, Ebert M, Fröb F, Kungl T, Arlt F, et al. Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nat Neurosci. 2016;19:1050-1059 pubmed publisher |
- western blot; mouse; 1:500; fig 1b
| Thakurela S, Garding A, Jung R, Müller C, Goebbels S, White R, et al. The transcriptome of mouse central nervous system myelin. Sci Rep. 2016;6:25828 pubmed publisher |
- western blot; mouse; 1:1000; loading ...; fig 5g
| Patzig J, Kusch K, Fledrich R, Eichel M, Lüders K, Möbius W, et al. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia. 2016;64:155-74 pubmed publisher |
- immunohistochemistry; human; 1:400; fig 2
| Ziskin J, Greicius M, Zhu W, Okumu A, Adams C, Plowey E. Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia. Acta Neuropathol Commun. 2015;3:43 pubmed publisher |
- immunohistochemistry - frozen section; human; 1:500
- immunohistochemistry - paraffin section; human; 1:500
| Schirmer L, Srivastava R, Kalluri S, Böttinger S, Herwerth M, Carassiti D, et al. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. Ann Neurol. 2014;75:810-28 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:2500
- immunohistochemistry - paraffin section; mouse; 1:2500
- immunohistochemistry - paraffin section; rat; 1:2500
| Schuh C, Wimmer I, Hametner S, Haider L, van Dam A, Liblau R, et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 2014;128:247-66 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:4000
| Locher H, de Groot J, van Iperen L, Huisman M, Frijns J, Chuva de Sousa Lopes S. Distribution and development of peripheral glial cells in the human fetal cochlea. PLoS ONE. 2014;9:e88066 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:2,500
| Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. 2013;74:848-61 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:2,500
| Misu T, Hoftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol. 2013;125:815-27 pubmed publisher |
| Witte M, Schumacher A, Mahler C, Bewersdorf J, Lehmitz J, Scheiter A, et al. Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis. Neuron. 2019;101:615-624.e5 pubmed publisher |
| Beckmann N, Giorgetti E, Neuhaus A, Zurbruegg S, Accart N, Smith P, et al. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945. Acta Neuropathol Commun. 2018;6:9 pubmed publisher |
| Karamita M, Barnum C, Mobius W, TANSEY M, Szymkowski D, Lassmann H, et al. Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. JCI Insight. 2017;2: pubmed publisher |
| Lagumersindez Denis N, Wrzos C, Mack M, Winkler A, van der Meer F, Reinert M, et al. Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol. 2017;134:15-34 pubmed publisher |
| Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, et al. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex. Brain Pathol. 2017;27:770-780 pubmed publisher |
